ATP and autophosphorylation driven conformational changes of HipA kinase revealed by ion mobility and crosslinking mass spectrometry by Wen, Y et al.
This is an author produced version of ATP and autophosphorylation driven conformational 
changes of HipA kinase revealed by ion mobility and crosslinking mass spectrometry.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/110581/
Article:
Wen, Y, Sobott, F and Devreese, B (2016) ATP and autophosphorylation driven 
conformational changes of HipA kinase revealed by ion mobility and crosslinking mass 
spectrometry. Analytical and Bioanalytical Chemistry, 408 (21). pp. 5925-5933. ISSN 
1618-2642 
https://doi.org/10.1007/s00216-016-9709-3
© Springer-Verlag Berlin Heidelberg 2016. This is an author produced version of a paper 
published in Analytical and Bioanalytical Chemistry. The final publication is available at 
Springer via https://doi.org/10.1007/s00216-016-9709-3. Uploaded in accordance with the 
publisher's self-archiving policy. 
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
1

ATP and autophosphorylation driven conformational changes of HipA 1
kinase revealed by ion mobility and crosslinking mass spectrometry 2
 3
 4
Running title: Mass spectrometric study of the HipAB complex 5
 6
Yurong Wen1, 2, Frank Sobott3, Bart Devreese2 7
1 Center for Translational Medicine, School of Life Science and Technology and Frontier 8
Institute of Science and Technology, Xian Jiaotong University, Xianning West Road 28, 9
710049 Xian, Shaanxi, China 10
2 Unit for Biological Mass Spectrometry and Proteomics, Laboratory for Protein 11
Biochemistry and Biomolecular Engineering (L-ProBE), Ghent University, K.L. 12
Ledeganckstraat 35, 9000 Ghent, Belgium. 13
3 Biomolecular & Analytical Mass Spectrometry Group and UA-VITO Center for Proteomics 14
(CFP-CEPROMA), University of Antwerp, 2020 Antwerp, Belgium;  15
 16
 17
 18
Address reprint requests to: Bart Devreese E-mail: Bart.Devreese@Ugent.be ; Fax: +32 9 264 19
53 38 Tel: +32 9 264 52 73. Unit for Biological Mass Spectrometry and Proteomics, 20
Laboratory for Protein Biochemistry and Biomolecular Engineering (L-ProBE), Ghent 21
University, K.L. Ledeganckstraat 35, 9000 Ghent, Belgium. 22
2

 23
Abstract 24
Toxin Antitoxin systems are genetic modules involved in a broad range of bacterial cellular 25
processes including persistence, multidrug resistance and tolerance, biofilm formation and 26
pathogenesis. In type II toxin antitoxin systems, both the toxin and antitoxin are proteins. In 27
the prototypic Escherichia coli HipA-HipB module, the antitoxin HipB forms a complex with 28
the protein kinase HipA, and sequesters it in the nucleoid. HipA is then no longer able to 29
phosphorylate glutamyl tRNA synthetase and this prevents the initiation of the forthcoming 30
stringent response. Here we investigated the assembly of the Shewanella oneidensis MR-1 31
HipA-HipB complex using native electrospray ion mobility mass spectrometry and chemical 32
crosslinking combined with mass spectrometry. We revealed that the HipA 33
autophosphorylation is accompanied with a large conformational change and confirmed 34
structural evidence that S. oneidensis MR-1 HipA-HipB assembly is distinct from the 35
prototypic E. coli HipA-HipB complex. 36
 37
  38
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
Introduction 39
Shewanella oneidensis MR-1 is a gram negative bacterium that is widely studied for its 40
potential application in bioremediation, microbial fuel cells and nanotechnology [1-3]. All of 41
these applications are highly dependent on the capacity of this bacterium to form biofilms. 42
We previously reported a role for the SO0706 gene in S.oneidensis MR-1 biofilm formation. 43
Indeed, transposon mutagenesis of this gene led to a 50% decrease of biofilm formation [4]. 44
The SO0706 gene encodes a protein that is homologous to the HipA toxin, a protein kinase 45
from Escherichia coli (28% identity). HipA was reported to belong to the Serine/Threonine 46
kinase family with similarity to the PI3/4 kinase super family. It can be partially 47
autophosphorylated in vivo or upon incubation with ATP and Mg2+ in vitro [5, 6]. While it 48
was originally believed that HipA halts ribosomal activity by phosphorylating elongation 49
factor Tu (EF-Tu) [7, 8], it was recently established that its natural substrate is actually 50
glutamyl-tRNA-synthetase. By phosporylating this enzyme at its ATP binding site, 51
uncharged glutamyl tRNA accumulates and the stringent response is activated [9, 10]. The 52
hipA gene forms an operon with hipB, which codes for a labile antitoxin that neutralizes 53
HipA activity by forming a HipAB complex. HipB is a helix-turn-helix motif containing 54
DNA-binding protein that mediates interactions with operators located upstream of the 55
HipAB operon to reduce HipA expression [7]. Recently, based on X-ray crystallographic data, 56
we demonstrated a distinct ternary assembly of the S. oneidensis HipAB with its operator 57
DNA [6]. Moreover, we showed that phosphorylated HipA binds with higher affinity to the 58
HipAB:DNA complex, whereas it was believed that phosphorylation would lead to release of 59
HipA from the complex in E.coli. The structural differences between the S. oneidensis and 60
E.coli HipAB-DNA complex formation indicated that mechanical regulation of HipAB toxin 61
antitoxin (TA) system in bacterial persistence may be diverse and still elusive [6]. 62
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We here provide the results of a set of mass spectrometric experiments involving ion mobility 63
mass spectrometry (IM-MS) and chemical crosslinking experiments that give further insights 64
in the S.oneidensis MR-1 HipA-HipB assembly, its regulation and the HipA kinase 65
mechanism. Firstly, IM-MS results indicated that HipA has three different conformational 66
states, i.e. apoHipA, Mg2+-ATP bound HipA and phosphorylated HipA (pHipA). We show 67
that binding of Mg2+-ATP drives the HipA conformational change required for its 68
autophosphorylation. Secondly, we confirm that the S.oneidensis MR-1 HipA-HipB assembly 69
is distinct from the homologue from E.coli as demonstrated by IM-MS and crosslinking mass 70
spectrometry (XL-MS) studies. Finally, our XL-MS data give further support to the pLoop 71
ejection as a direct consequence of HipA autophosphorylation. 72
 73
Experimental procedures 74
Materials 75
All chemicals were obtained from Sigma-Aldrich (St-Louis, MO, USA) unless otherwise 76
stated. LC-MS grade solvents were from Biosolve (Valkenswaard, NL).  77
Preparation of protein and protein-DNA complex samples 78
S.oneidensis MR-1 HipA, HipAD306Q, HipB proteins with an N-terminal His-tag were 79
expressed in E.coli BL21(DE3) cells using the pET15b expression vector (EMD Biosciences, 80
San Diego, CA, USA). Stable overexpression of the target proteins was obtained by inducing 81
the cultures for 1h (HipA) or 4h (HipB) with 1mM isopropyl ȕ-D-1-thiogalactopyranoside 82
(IPTG) (Duchefa Biochemie, Haarlem, NL) when cultures were grown to an OD600 of 0.6-83
0.7 in LB medium supplied with carbenicillin (100µg/ml; P212121, Ypsilanti, MO, USA) at 84
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
37ºC. Detailed overexpression and purification protocols were previously described [6]. The 85
double stranded operator DNA was obtained from annealing two single primers  5-86
ATTAGGTGTACTTATCTACACTTTTT-3, 5-87
AAAAAGTGTAGATAAGTACACCTAAT-3 (obtained from Integrated DNA 88
Technologies, Leuven, BE). The HipAB and HipB:DNA complex were formed by mixing 89
proper ratios and subsequently purified by gel filtration on a Hiload 16/60 Superdex 200 90
chromatography column using an Akta Purifier system (GE Healthcare, Diegem, BE). The 91
concentrations of the samples are determined with a Nanodrop instrument (Thermo Fisher 92
Scientific, Waltham, MA, USA). 93
Electrospray ionization ion mobility mass spectrometry analysis 94
Purified samples with a protein concentration of 10-20µM were buffer exchanged against 95
100-200mM ammonium acetate (pH 7) using Micro Biospin 6 columns (Bio-Rad, Hercules, 96
CA, USA) just prior to MS analysis. The Mg2+-ATP HipA complex was obtained by adding 97
5mM ATP and 10mM MgCl2 to the buffer exchanged sample just before the MS 98
measurement. The traveling wave ion mobility MS measurements were performed on a q-99
IMS-TOF instrument (Synapt G1 HDMS, Waters, Manchester, UK) equipped with a 100
Nanomate electrospray ionization source (Advion, Ithaca, NY, USA). The samples were 101
sprayed using a capillary voltage of 1.65-1.75kV using the type D nano-ESI chip (Advion, 102
Ithaca, NY, USA). The IM separator, filled with Nitrogen, was pressurized at 0.5 mbar. The 103
applied instrumental parameters were: sample cone 80V, bias 35V, Trap CE 10V, Transfer 104
CE 4V, ion mobility wave velocity 400m/s, wave height 12V, transfer wave velocity 140m/s, 105
wave height 5V. Ions underwent TOF analysis with m/z range from 1500 or 2000 to 8000. 106
The TOF tube vacuum pressure maintained at around 9.5×10-7 mbar. Denatured myoglobin 107
ions were used for the Nitrogen CCS calibration and all the other instrument parameters were 108
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
tuned by following the protocol reported by Ruotolo et al. [11]. The CCS calibration curve 109
generated from DriftScope software is shown in supplementary material (Figure S1). The 110
experimental CCS value was obtained from triplicate measurements using the same IM 111
parameters. All the data were analyzed using Masslynx V4.1 and DriftScope V2.3 (Waters) 112
with minimal smoothing and background subtraction.  For comparison with the experimental 113
CCS values, the PA CCS value was multiplied by a scaling factor of 1.14 [12]. 114
The theoretical CCS of S.oneidensis MR-1 and E.coli HipAB assemblies were calculated by 115
applying the Projection Approximation (PA) mode [12] using the PDB data files for E.coli 116
(3DNV, 3FBR and 3TPE) and S.oneidensis MR-1 (4PU3, 4PU5 and 4PU7) containing the 117
atomic resolution crystal structures of the different subunits and DNA complexes [6-8]. 118
Chemical crosslinking proteolysis and LC-MS analysis of crosslinked 119
peptides 120
We selected Bis[sulfosuccinimidyl] suberate (BS3, Thermo Scientific Pierce, Rockford, IL, 121
USA) for the crosslinking experiments. We prepared a stock concentration of 100mM or 122
200mM BS3 in water. We then optimized crosslinking conditions by applying different BS3 123
concentrations (0mM, 0.5mM, 1mM, 2mM and 5mM) and incubation time (15min, 30min, 124
45min, 60min and 120min). Incubation at both 4°C and at room temperature was also 125
compared. The crosslinking efficiency was evaluated by SDS-PAGE. Based on this 126
optimization, it was decided to add 1mM or 2mM of BS3 to the purified protein or protein 127
complex and the mixture was incubated at room temperature for 45-60min. The reaction was 128
quenched by the addition of Tris buffer pH7.0 to a final concentration of 50mM. The sample 129
was subsequently digested overnight with trypsin (Porcine sequencing grade, Promega, 130
Madison, MA, USA) at 37 °C using an enzyme to protein ratio of 1:20. The sample buffer 131
was exchanged to 50mM NH4HCO3 using a Superdex peptide PC 3.2/30 column which also 132
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allowed to enrich the larger and crosslinked peptides. The fractions that eluted between 0.9-133
1.5 ml of elution buffer were pooled, dried and dissolved using 0.1% formic acid aqueous 134
solution prior to LC-MS analysis. The digestion mixtures were analyzed by nanoESI LC-135
MS/MS. Peptides were separated using an Agilent 1200 HPLC (Agilent, Santa Clara, CA, 136
USA) at a flow rate of 300nL/min. A C18 Acclaim PepMap300 5µm (Thermo Scientific 137
Dionex, Sunnyvale, CA, USA) column was used to trap the peptides followed by separation 138
on a C18 Acclaim PepMap100 (3µm) 75µm×250mm column (Thermo Scientific Dionex). 139
Peptides were eluted with a gradient of acetonitrile. Buffer A contained 0.1% formic acid in 140
water and buffer B was 0.1% formic acid in acetonitrile. The applied gradient was:  2%B to 141
10%B in 10min, 10%B to 40%B in 30min, 40% to 80% in 10min, and 80% to 2% in 5min. 142
The column outlet was directly interfaced to a Nanomate electrospray source (Advion) 143
equipped with D-chips connected to an LTQ-FT Fourier transform ion cyclotron resonance 144
Mass spectrometer (Thermo Fisher Scientific). Data dependent analysis was carried out using 145
a resolution of 100,000. MS spectra were acquired over an m/z range of 150-2000 with a 146
charge filter above 1 and the 10 highest peaks were submitted to MS/MS scans using 147
threshold energy of 35V for collision induced dissociation (CID). The chemical crosslink 148
data analysis was performed using the pLink program [13]. 149
Results and Discussion 150
HipA has three different detectable conformational states: apoHipA, Mg-151
ATP bound HipA, phosphorylated HipA 152
We purified the S.oneidensis MR-1 HipA, produced as a recombinant protein in E. coli. The 153
protein is unstable under denaturing condition (50%ACN, 0.1%FA), and we could not obtain 154
an electrospray ionization mass spectrum when the protein was dissolved at low pH because 155
the protein precipitated. However, at pH 7, we could obtain good quality native electrospray 156
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
mass spectrometry data and we investigated the protein by ion mobility MS (IM-MS) to 157
further characterize its molecular shape. Surprisingly, ion mobility analysis of freshly 158
purified recombinant HipA revealed two distinct conformational populations (Figure 1a). The 159
two populations (ATDs) from the gas phase separation were further extracted using 160
Driftscope analysis (Table 1). The mass of one conformational form corresponded well to the 161
theoretical mass of the HipA protein (50767.6±5.3 Da). The mass of the form that moved 162
faster in the ion mobility device was slightly higher (50878.1±18.8 Da), and the mass 163
difference could correspond to a phosphorylation in addition to binding a small alkali metal 164
like Mg2+. It is previously reported that also E.coli HipA purification results in a partially 165
phosphorylated population which was considered to be the inactive form indicating that 166
phosphorylation of the enzyme results in growth arrest reversion [8]. The sample used for this 167
mass spectrometry experiment was from the same batch that was also used for determination 168
of the crystal structure of the HipAB-DNA complex by X-ray diffraction analysis [6] . We 169
previously performed a tryptic digest of this sample and analyzed the resulting peptides by 170
LC-MS and found that recombinant HipA is a mixture of phosphorylated HipA (pHipA) and 171
non-phosphorylated HipA (apoHipA). These data further indicated that there is around 5-8 % 172
of pHipA that is phosphorylated at Ser147 [6].  173
In some preparations of the recombinant HipA, we observed that the phosphorylated form 174
was nearly absent. When analyzing these samples using IM-MS, only one population was 175
observed indicating that the mobility difference is a direct consequence of the 176
phosphorylation (Figure 1b). Not surprisingly, phosphorylation of HipA results in a slightly 177
shifted Gaussian distribution which can be explained by a single positive charge reduction. 178
The drift time of pHipA and apoHipA 13+ ions is around 9.6ms and 13.4ms, respectively, 179
which corresponds to a collisional cross section (CCS) difference of almost 950Å2 between 180
these 2 forms (Figure 1d). It should be mentioned that phosphorylation of S147 leads to an 181
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additional conformational change through pLoop ejection [6]. As a matter of fact, based on 182
the atomic resolution structure, this would lead to an increase of CCS of only 52 Å2. Our 183
instrument does not possess the IM resolution (10-15 for Synapt G1) to distinguish such a 184
small conformational change. The change in CCS that we observe can thus not be explained 185
by the presence of the phosphate group alone, and suggests that pHipA has a more compact 186
conformation compared to apoHipA. In addition, the ATD peak width (7ms in apoHipA (13+ 187
ion) vs 3ms for HipA (13+)) could indicate that apoHipA exists in multiple conformations 188
(Figure 1a and 1c) and is thus flexible. Structural flexibility compromises protein 189
crystallization and could explain why we obtained only X-ray diffracting crystals from the 190
phosphorylated form even when it coexisted with the apo form. 191
We further analyzed the effect of binding of Mg2+-ATP on the HipA conformation. Freshly 192
purified HipA was incubated in a pH neutralized buffer containing 5mM ATP and 10mM 193
MgCl2. The ion mobility shift compared to apoHipA indicates formation of the Mg2+-ATP 194
complex to HipA which causes a shift to a more compact conformation with a CCS similar as 195
for pHipA (Figure 1d) (Table 1, Supplementary Table S1). The CCS represents also a value 196
for the solvent accessible surface area (SASA) in a globular protein when corrected for the 197
molecular weight of the protein [14]. The SASA per Da of the apoHipA decreases from 0.098 198
Å2/Da to 0.073 Å2/Da upon the Mg2+-ATP binding. Conformational change induced by 199
ligand binding is a phenomenon that has been observed in several other ion mobility mass 200
spectrometry experiments [15, 16]. More specific, nucleotide dependent conformational 201
changes in proteins with ATPase activity are well described [17] and illustrated by ion 202
mobility MS recently [18]. We observed also some oligomeric HipA possibly due to the 203
Mg2+ and concentration effect. There is so far no evidence for a physiological role for dimeric 204
HipA. However, autophosphorylation of HipA involves an intermolecular transfer of a 205
phosphate group from one HipA molecule to another [8], requiring the direct contact between 206
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two HipA molecules with low affinity. Analysis of the tryptic digest of this sample by LC-207
MS indicated that after incubation with ATP and Mg2+, the relative amount of pHipA 208
increased up to approximately 45-50% of the total HipA [6]. Crystal structure analysis 209
indicated that the link between the C-terminal and N-terminal domains of HipA could be 210
flexible and that there are five loops between those two domains involved in the ATP and 211
Mg2+ binding to HipA [6]. The large conformational change represented by this difference in 212
ion mobility is explained by considering that those five loops form a pocket that could pull 213
together the N- and C-terminal domains in order to tightly anchor the Mg2+-ATP binding, 214
hence resulting in a substantial conformational change similar to the one observed in many 215
kinases. Therefore, we conclude that the conformational change between the apoHipA and 216
Mg2+-ATP binding HipA results in an intermediate conformation state which serves for the 217
HipA phosphorylation (Figure 1e).  218
Characterization of HipA, HipB and their operator DNA interactions by 219
ion mobility mass spectrometry reveals a distinct assembly with respect to 220
S.oneidensis MR-1 and E.coli HipAB complexes 221
hipA and its upstream linked gene hipB form a toxin-antitoxin module which is recognized as 222
a major factor involved in persistence [19]. HipB is a Helix-Turn-Helix (HTH) DNA-binding 223
protein that functions as the antitoxin. It neutralizes HipA activity by forming a complex 224
sequestering HipA in the nucleoid following binding to the operators upstream of the HipAB 225
TA operon. Formation of this complex suppresses the transcription of the hipA gene [7, 8]. 226
Here, an IM-MS approach was applied to investigate the assembly between Mg2+-ATP-HipA, 227
HipB and its operator DNA. Native ESI analysis confirmed that HipB is a dimer with 228
molecular weight 21838.6±1.1 Da (Figure S2). Similarly, it was determined that this dimer 229
interacts with 2 molecules of HipA forming a HipA2B2 heterotetramer with molecular weight 230
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
127940.2±46.9 Da (Figure 2a). Several other species including the HipB dimer, Mg2+-ATP-231
HipA monomer, Mg2+-ATP-HipAB2 and Mg2+-ATP-HipA2B2 were nicely separated in the 232
IM mode (Figure 2b). Additionally, we also performed ESI-MS analysis on HipB in complex 233
with a single operator DNA showing that the HipB2 dimer can interact with a single operator 234
DNA fragment (Figure 2c). We also tested interaction with a DNA fragment containing 2 235
operator sites showing binding to 2 HipB2 dimers (data not shown). In the HipAB operon, 236
there are 4 identical palindromic operators equally separated by 34bp which may involve 4 237
HipB2 dimer molecules binding. Whether those 4 operators act cooperatively is still elusive. 238
To gain more insight into the HipA and HipB assembly, the CCS values were experimentally 239
determined. The experimental CCS fits well to the theoretical CCS generated using the PA 240
model from the S.oneidensis MR-1 crystal structure data, with a small deviation of 2-4%. The 241
theoretical CCS value for the HipAB complex of E.coli is quite different, reflecting the 242
distinct structural assembly of both complexes  [6].  243
The experimental CCSs of the different proteins and assemblies are well correlated in a linear 244
relationship with their respective molecular weight (Figure 2d). Such a relationship is 245
indicative for an extended, linear arrangement of building blocks as represented by the 246
structural assembly of the complez [11].  247
Probing the HipA kinase conformational changes upon phosphorylation 248
using chemical crosslinking 249
Chemical crosslinking combined with mass spectrometry was used to further probe the 250
assembly of the S.oneidensis MR-1 HipA-HipB TA complex. After crosslinking the protein 251
or protein complex using BS3, tryptic peptides were generated and analyzed using LC-MS on 252
a high resolution FT-ICR MS instrument. Data were analyzed using the pLink software 253
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
which revealed 6 crosslinked peptides, including both inter- and intra-crosslinked peptides 254
(Table 2).  255
The spacer length of the BS3 crosslinker is 11.4Å and an efficient crosslink distance between 256
two lysine residue CĮ atoms is reported to be approximately 5-35Å [13, 20, 21]. Distance 257
restraints are generated and nicely fit the values reported for BS3 crosslinkers (Figure 3a). It 258
is noteworthy that two distinct crosslinked sites (K35 and K64) were observed at the N 259
terminus of HipB, which could reflect the flexibility of the HipB N terminal region. The 260
distance of the intermolecular crosslink between HipA and HipB is somewhat at the limit of 261
the method, but it should be realized that the figure is derived from the HipAB-DNA complex, 262
and some more structural flexibility is expected when no DNA is bound. Surprisingly, when 263
we applied the chemical crosslinking approach to pHipA, an additional crosslinked peptide 264
was observed between K143 and K264. The MS/MS spectrum of this crosslinked peptide was 265
highly conclusive as most of the peaks could be assigned (Figure 3b). K143 is positioned 266
inside the reported phosphorylation loop (pLoop) of which repositioning is crucial for the 267
modulation of the kinase activity of HipA. Interestingly, this crosslink was not observed in 268
the HipA D306Q mutant that was reported not to undergo phosphorylation. Indeed, based on 269
data from the crystal structure of pHipA and the AMPPNP bound HipA (unphosphorylated), 270
the distance observed between K143 and K264 are 18.6Å and 40.3Å respectively (Figure 3c). 271
Without the phosphorylation, those two residues are too far away to be crosslinked. Moreover, 272
they are separated by a helix in HipA bound to the ATP-mimicking compound AMPPNP. 273
This indicates that the K143 and K264 crosslinked peptide observed from the pHipA 274
describes the phosphorylation pLoop conformational change which we could not observe 275
using ion mobility experiments. 276
 277
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Conclusion 278
Mass spectrometry combined with ion mobility measurements and chemical crosslinking is a 279
powerful tool for the study of protein dynamics. In this study, three different conformations 280
of recombinant HipA were observed in ion mobility MS experiments, indicating that the 281
HipA kinase undergoes a large conformational change upon binding Mg2+-ATP followed by 282
p-loop ejection upon autophosphorylation. ESI-IM-MS also allowed probing of the weak 283
non-covalent protein-protein interaction: the observation of dimeric HipA upon ATP and 284
Mg2+ could reflect the trans-autophosphorylation state between two HipA molecules. 285
Furthermore, the HipA kinase activity loop ejection mechanism was characterized through 286
the distance restraint information generated by the chemical crosslinking mass spectrometry 287
approach. The native ion mobility mass spectrometry data represent good correlations with 288
the atomic resolution models revealed by X-ray crystallography and revealed a distinct 289
assembly between E.coli and S.oneidensis MR-1 HipAB and their DNA binding structure.  290
Hence, the successful characterization of the S.oneidensis MR-1 HipA-HipB assembly and 291
mechanism through combination of IM-MS and XL-MS established an example of gathering 292
information on macromolecular assembly using an integrated MS approach. Toxin-antitoxin 293
systems are mostly linked with intrinsically disordered domains or protein such as the phd-294
doc system [22]. Unquestionably, adding MS to an integrative structural biology approach in 295
the study of TA systems can complement the crystallography and provide substantial 296
additional information for non-crystallizing intermediates and to reveal transient interactions. 297
Recently, these mass spectrometry approaches were summarized to be applicable in 298
pharmaceutical drug discovery and development in applications to study the conformational 299
transition and protein ligand screening [23, 24]. The toxin-antitoxin systems are proposed as 300
an attractive target for next generation antimicrobial drug discovery, which may aid in the 301
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
fight to major challenges under current antibiotic treatment such as persistence, multidrug 302
tolerance and multidrug resistance etc [25-27]. The successful probing of the conformational 303
change between the HipA with its ligand binding and post-translational modification revealed 304
the potential of the MS-based approach in the investigation of protein ligand complexes and 305
can further lead to the pharmaceutical exploitation of the TA system as an antimicrobial drug 306
target. 307
  308
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Table 1 Experimental and theoretical collision cross section and molecular weight 395
 apoHipA 
HipA 
ATP:Mg 
pHipA HipB2* 
HipAB2 
ATP:Mg 
HipA2B2 
ATP:Mg 
Experimental 
CCS(Å2)# 
4962 (186) 3822(34) 3744(125) 2629(70) 5249(152) 8116(14) 
PA S.O. 
CCS(Å2) 
No data 3628 3576 2585 5273 8143 
PA E.coli 
CCS(Å2) 
No data 3276 3160 2235 4366 6717 
Experimental 
MW (Da) 
50768±5 51336±63 50878±19 
21839±1 
25344±2 
76659±33 127940±47 
Theoretical 
MW (Da) 
50764 51320 50844 
21839 
25341 
76660 127980 
*The two different experimental and theoretical molecular weights indicate the state with or without 396
His tag. #The Experimental CCS is the average value generated from at least 3 replicate measurements. 397
The value between brackets is the standard deviation 398
  399
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 401
Table 2 Crosslinked peptides between HipA and HipB assembly identified by pLink 402
N
o. 
Sequence 1(X-linked residue) 
X-linked position in sequence 
Sequence 2(X-linked 
residue) 
X-linked position in 
sequence 
pLink 
Score 
Calc_M CĮ-CĮ 
distance 
Mass 
error 
(ppm) 
1 IEDPTMWPMEIWDGKPR(15) 
HipA(143) 
DVKDIR(3) 
HipA(264) 
7.41E-04 2982.46 18.6 Å 0.30 
 
2 RKSAALTQDVAAMLCGVTK(2) 
HipB(39) 
KYER(1) 
HipA(252) 
8.57E-02 2694.42 
 
36.6 Å 0.62 
 
3 VEKGEDVYISTVFK(3) 
HipB(64) 
KTLIR(1) 
HipB(57) 
9.95E-09 2380.33 10.6 Å 
 
0.013 
 
4 VYEDTLLETIMASPLNQQSLGLLIKER(25) 
HipB(35) 
VEKGEDVYISTVFK(3) 
HipB(64) 
4.36E-02 4824.55 
 
28.2 Å 1.27 
5 VEKGEDVYISTVFK(3) 
HipB(64) 
GSHMNGTDIK(1) 
HipB(-2°) 
9.56E-02 2809.38
4 
ND* -4.66 
6 VYEDTLLETIMASPLNQQSLGLLIKER(25) 
HipB(35) 
GSHMNGTDIK(1) 
HipB(-2°) 
8.44E-01 4270.18 ND* -0.89 
*No density of HipB in the crystal structure because of its flexibility. 403
° Cross linked at amino terminus, -2 refers to the fact that HipB was produced as a recombinant 404
protein with HisTag. The actual start of the protein is at His. 405
  406
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Figure Legends: 408
Figure 1. IM-MS analysis of recombinant HipA. a. Native mass spectrum and drift time vs 409
m/z plot of a freshly prepared HipA sample. The plot displays two distinct populations, i.e. 410
apoHipA and phosphorylated HipA (pHipA). The two populations that separated in the gas 411
phase are encircled. b. Native mass spectrum and drift time vs m/z plot of a sample 412
containing only nonphosphorylated HipA alone (apoHipA). c. Drift time profiles of the 13+ 413
ion of pHipA and apoHipA respectively. Calculation of the collision cross section indicated a 414
value of 3800Å2 for pHipA and 4750Å2 apoHipA, respectively. d. Native mass spectrum and 415
drift time vs m/z plot of holoHipA regard to ATP Mg2+ bound HipA. The drift time of 416
holoHipA (Green) was shown to be more corresponding to the pHipA than of apoHipA. The dimer 417
population of Mg2+-ATP bound HipA (Black) could reflect the transient interaction necessary to 418
perform the intermolecular autophosphorylation. e. Schematic view of the three different HipA 419
conformations. Upon binding of ATP and Mg2+, apoHipA is phosphorylated transforming the 420
protein to a more compact pHipA conformation. 421
Figure 2. IM-MS characterization of HipA-HipB assembly. a. IM-MS measurement of the 422
ATP-Mg2+ bound HipA complexed with HipB. Both the electrospray spectrum and b. the 423
drift time vs m/z-drift time view are shown, the charges of the 4 populations are denoted (A: 424
ATP-Mg2+ bound HipA B: HipB2, , C: ATP-Mg2+ bound HipAB2, D: ATP-Mg2+ bound 425
HipA2B2). The 4 populations are also circled in the m/z-drift time view. c. Native ESI-MS 426
spectrum of HipB2DNA complex. d. Plot of experimental and theoretical PA model CCS vs 427
molecular weight of HipB2, HipA, HipAB2 and HipA2B2.  428
Figure 3. Cross-linking the HipAB complex with BS-3. a. The crosslinked peptides are 429
denoted on the S.oneidensis MR-1 HipA2B2 3D dimensional structure accompanied with the 430
distance restraints. The structural model of S.oneidensis MR-1 HipA2B2 was generated from 431
21

PDB: 4PU3 b MS/MS spectrum of the pHipA crosslinked peptide containing K143 and K264, 432
displayed in the output generated from pLink. c. Three dimensional structures of pHipA and 433
HipA, binding the ATP mimicking AMPNP. The distances between K143 and K 264 are 434
18.6Å and 40.3Å respectively indicating that in the AMPPNP bound HipA, the distance 435
between these residues is too large and crosslinking is further hindered by a helical structure. 436
The observation of the crosslinked K143 and K264 in the pHipA thus reflects the pLoop 437
ejection upon of HipA phosphorylation. The atomic structure representation of S.oneidensis 438
MR-1 HipA and pHipA were generated from PDB: 4PU3 and 4PU5. 439
 440
 441
 442
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 444
 445
 446
 447
 448
 449
 450
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Supplementary information 451
Table S1. Experimental CCS values obtained from replicate experiments of the 452
different complexes. 453
Figure S1. Denatured Myoglobin CCS calibration curve generated from Driftscope.   454
Figure S2. Native mass spectrum of HipB indicated HipB exists in dimeric form. 455
Figure S3. MS/MS spectrum of the crosslinked peptide containing K143 and K264 in pHipA 456
screened from pLink and reanalyzed by xlink. 457
 458




Table S1. Replicate measurement of the CCS supplemented to Table 1. The CCS value shown in 
Table 1 is the average of 3 or 4 measurements in the same IM parameters. 
Experimental 
CCS (Å2) 
1st  2nd 
 
3rd 
 
4th 
 
Average 
 
Standard 
deviation 
apoHipA 4820 4751 5216 5060 4962 186 
HipA 
ATP:Mg 
3800 3836 3882  3822 34 
pHipA 3610 3817 3638 3910 3744 125 
HipB2 2596 2565 2726  2629 70 
HipAB2 
ATP:Mg 
5150 5464 5132  5249 152 
HipA2B2 
ATP:Mg 
8106 8105 8136  8116 14 
Table S1. Replicate measurement of the CCS supplemented to Table 1. The CCS value shown in 
Table 1 is the average of 3 or 4 measurements in the same IM parameters. 
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